Compare Abeona Therapeutics Inc (ABEO) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs PPG Industries, Inc. — how do they compare? Abeona Therapeutics Inc trades at $6.78 (market cap $373.32M), while PPG Industries, Inc. trades at $114.52 (market cap $26.80B). The key difference: PPG Industries, Inc. is far larger — about 71.8× Abeona Therapeutics Inc's market cap, and PPG Industries, Inc. pays a 2.36% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | PPG | |
|---|---|---|
Market Cap | $373.32M | $26.80B |
Sector | Health | Basic Materials |
52-Week High | $7.23 | $131.56 |
52-Week Low | $4.17 | $94.34 |
Enterprise Value | $228.22M | $32.90B |
Dividend Yield | — | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
PPG Industries (PPG) trades at $120.22, down 4.08% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings of $1.83 per share, beating estimates, and maintains solid profitability with a net margin of 9.83% and ROE of 21.09%. Recent news highlights innovation in aerospace and marine coatings, including a green chemistry award for SIGMAGLIDE 2390 coating.
The outlook is supported by analyst consensus with a $129.40 price target and 52.63% buy ratings, but risks include volume softness and margin pressure. Earnings growth and sustainability initiatives are key catalysts, though macroeconomic headwinds and competitive pressures remain concerns for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
